Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Fuster

Showing results (51-60 of 512) with videos related to

Pageof 52
Sort By:
Annals of Internal Medicine|October 27, 1997
The generalist/cardiovascular specialist: a proposal for a new training trackV Fuster, I S Nash
International Journal of Cardiology|July 1, 1983
Coronary collateral vessels and myocardial protectionJ A Ambrose, V Fuster
Mayo Clinic Proceedings|April 1, 1981
Series on pharmacology in practice. 10. Antithrombotic therapy: role of platelet-inhibitor drugs. III. Management of arterial thromboembolic and atherosclerotic disease (third of three parts)V Fuster, J H Chesebro
The New England Journal of Medicine|October 16, 1986
Mechanisms of unstable anginaV Fuster, J H Chesebro
The American Journal of Cardiology|July 28, 2001
The human high-risk plaque and its detection by magnetic resonance imagingZ A Fayad, V Fuster
Annals of the New York Academy of Sciences|June 24, 2000
Characterization of atherosclerotic plaques by magnetic resonance imagingZ A Fayad, V Fuster
Circulation Research|August 18, 2001
Clinical imaging of the high-risk or vulnerable atherosclerotic plaqueZ A Fayad, V Fuster
JAMA|November 22, 2001
Inflammatory markers in coronary artery disease: let prevention douse the flamesD A Vorchheimer, V Fuster
Clinical Pharmacology and Therapeutics|September 9, 2011
From treating complex coronary artery disease to promoting cardiovascular health: therapeutic transitions and challenges, 2010-2020J C Kovacic, V Fuster
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1985
Coronary artery bypass grafting. A model for the understanding of the progression of atherosclerotic disease and the role of pharmacological interventionV Fuster, J H Chesebro
Pageof 52

Showing results (51-60 of 512) with videos related to

Sort By:
Pageof 52
Annals of Internal Medicine|October 27, 1997
The generalist/cardiovascular specialist: a proposal for a new training trackV Fuster, I S Nash
International Journal of Cardiology|July 1, 1983
Coronary collateral vessels and myocardial protectionJ A Ambrose, V Fuster
Mayo Clinic Proceedings|April 1, 1981
Series on pharmacology in practice. 10. Antithrombotic therapy: role of platelet-inhibitor drugs. III. Management of arterial thromboembolic and atherosclerotic disease (third of three parts)V Fuster, J H Chesebro
The New England Journal of Medicine|October 16, 1986
Mechanisms of unstable anginaV Fuster, J H Chesebro
The American Journal of Cardiology|July 28, 2001
The human high-risk plaque and its detection by magnetic resonance imagingZ A Fayad, V Fuster
Annals of the New York Academy of Sciences|June 24, 2000
Characterization of atherosclerotic plaques by magnetic resonance imagingZ A Fayad, V Fuster
Circulation Research|August 18, 2001
Clinical imaging of the high-risk or vulnerable atherosclerotic plaqueZ A Fayad, V Fuster
JAMA|November 22, 2001
Inflammatory markers in coronary artery disease: let prevention douse the flamesD A Vorchheimer, V Fuster
Clinical Pharmacology and Therapeutics|September 9, 2011
From treating complex coronary artery disease to promoting cardiovascular health: therapeutic transitions and challenges, 2010-2020J C Kovacic, V Fuster
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1985
Coronary artery bypass grafting. A model for the understanding of the progression of atherosclerotic disease and the role of pharmacological interventionV Fuster, J H Chesebro
Pageof 52